Designed to advance greater access to biosimilars in Mexico, this forum convenes top decision-makers from manufacturers, regulators, and healthcare providers. Featuring dynamic presentations, interactive panels, and networking spaces, the event delves into policy reforms, investment strategies, and environmental sustainability in biosimilar production. The forum also explores innovative regulatory approaches and public-private collaborations aimed at accelerating approvals and improving affordability, reinforcing Mexico’s competitive position in the biotechnology sector.
Key objectives:
- Evaluate policies to expand biosimilar access for vulnerable populations and redistribute healthcare savings to improve equity.
- Analyze strategies to position Mexico as a competitive destination for biotechnology investments, exploring regulatory and market opportunities.
- Discuss environmental challenges in biosimilar production and explore solutions for sustainable manufacturing practices aligned with global goals.
- Explore strategies to accelerate biosimilar approvals in Mexico, maintaining safety and efficacy standards while fostering public-private partnerships.
BIA members can request BioPartner UK for a discount code.
